|
| |
Men's Health Therapeutics Market to 2017 - Availability of Generic Sildenafil from 2012 to Restrain Market Growth
|
Published: Jan 2012 | Pages: 130 | Pub ID: MM1326972159 |
|
|
|
 |
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Men’s Health Therapeutics Market to 2017 - Introduction
2.1 Overview
2.2 GBI Research Report Guidance
3 Men’s Health Therapeutics Market to 2017 - Market Characterization
3.1 Overview
3.2 Market Forecasts
3.3 Global Generic/Off-label Share
3.4 Annual Cost of Treatment
3.5 Treatment Usage Patterns
3.5.1 Diseased Population
3.5.2 Treatment Seeking Population
3.5.3 Diagnosed Population
3.5.4 Treated Population
3.5.5 Drivers and Restraints of the Men’s Health Therapeutics Market
4 Men’s Health Therapeutics Market To 2017 - Geographical Landscape
4.1 Market Forecasts by Country
4.2 The US
4.2.1 Market Forecasts
4.2.2 Annual Cost of Treatment
4.2.3 Treatment Usage Patterns
4.3 Top Five Countries in Europe
4.3.1 Market Forecasts
4.3.2 Annual Cost of Treatment
4.3.3 Treatment Usage Patterns
4.4 Japan
4.4.1 Market Forecasts
4.4.2 Annual Cost of Treatment
4.4.3 Treatment Usage Patterns
5 Men’s Health Therapeutics Market to 2017 - Therapeutic Landscape
5.1 Global Erectile Dysfunction (ED) Therapeutics Market
5.1.1 Market Overview
5.1.2 Market Forecasts
5.1.3 Revenue Analysis by Country
5.1.4 Global Generic/Off-Label Share
5.1.5 Annual Cost of Treatment
5.1.6 Treatment Flow Algorithm
5.1.7 Treatment Usage Patterns
5.1.8 Product Analysis
5.1.9 Drivers and Restraints of the ED Therapeutics Market
5.2 Global Male Hypogonadism Therapeutics Market
5.2.1 Market Overview
5.2.2 Market Forecasts
5.2.3 Revenue Analysis by Country
5.2.4 Global Generic/Off-label Share
5.2.5 Annual Cost of Treatment
5.2.6 Treatment Flow Algorithm
5.2.7 Treatment Usage Patterns
5.2.8 Product Analysis
5.2.9 Drivers and Restraints of the Male Hypogonadism Therapeutics Market
5.3 Global Premature Ejaculation (PE) Therapeutics Market
5.3.1 Market Overview
5.3.2 Market Forecasts
5.3.3 Revenue by Country
5.3.4 Global Generic/Off-Label Share
5.3.5 Annual Cost of Treatment
5.3.6 Treatment Flow Algorithm
5.3.7 Treatment Usage Patterns
5.3.8 Product Analysis
5.3.9 Drivers and Restraints of the PE Therapeutics Market
5.4 Global Benign Prostatic Hyperplasia (BPH) Market
5.4.1 Overview
5.4.2 Market Forecasts
5.4.3 Revenue Analysis by Country
5.4.4 Generics/Off-Label Share
5.4.5 Annual Cost of Treatment
5.4.6 Treatment Flow Algorithm
5.4.7 Treatment Usage Patterns
5.4.8 Product Analysis
5.4.9 Drivers and Restraints of the BPH Therapeutics Market
6 Men’s Health Therapeutics Market to 2017 - Pipeline Analysis
6.1 Overview
6.2 Research and Development Pipeline by Indication
6.3 Research and Development by Phase of Development
6.4 Research and Development Pipeline - Erectile Dysfunction
6.4.1 Pipeline by Clinical Phases of Development
6.4.2 Profiles of Key Late-Stage Drugs in the Erectile Dysfunction Market
6.5 Research and Development Pipeline - Premature Ejaculation
6.5.1 Pipeline by Clinical Phases of Development
6.5.2 Profiles of Key Late-Stage Drugs in the Premature Ejaculation Market
6.6 Research and Development Pipeline - Male Hypogonadism
6.6.1 Pipeline by Clinical Phases of Development
6.6.2 Profiles of Key Late-Stage Drugs in the Male Hypogonadism Market
6.7 Research and Development Pipeline - Benign Prostatic Hyperplasia
6.7.1 Pipeline by Clinical Phases of Development
6.7.2 Profiles of Key Late-Stage Drugs in the Benign Prostatic Hyperplasia Market
7 Men’s Health Therapeutics Market to 2017 - Competitive Landscape
7.1 Overview
7.2 Company Profiles
7.2.1 Pfizer Inc.
7.2.2 Eli Lilly and Company
7.2.3 GlaxoSmithKline, Inc
7.2.4 Abbott Laboratories
7.2.5 Endo Pharmaceuticals Holding Inc.
7.2.6 Bayer Healthcare AG
7.2.7 Johnson & Johnson
7.2.8 VIVUS, Inc.
7.2.9 Auxilium Pharmaceuticals, Inc.
8 Men’s Health Therapeutics Market to 2017 - Strategic Consolidations
8.1 Overview
8.2 Mergers and Acquisitions
8.2.1 Overview
8.2.2 Major M&A Deals
8.3 Licensing Agreements
8.3.1 Deals by Geography
8.3.2 Deals by Value
8.3.3 Deals by Year
8.4 Major Licensing Agreements
8.5 Co-Development Deals
8.5.1 Major Co-Development Deals
9 Men’s Health Therapeutics Market to 2017 - Appendix
9.1 Market Definitions
9.2 Abbreviations
9.3 Research Methodology
9.3.1 Coverage
9.3.2 Secondary Research
9.3.3 Primary Research
9.3.4 Therapeutic Landscape
9.3.5 Epidemiology-based Forecasting
9.3.6 Market Size by Geography
9.3.7 Geographical Landscape
9.3.8 Pipeline Analysis
9.3.9 Competitive Landscape
9.3.10 Expert Panel Validation
9.4 Contact Us
9.5 Disclaimer
9.6 Sources |
|
| By: GBI Research |
|
|
| |
|
|
|
US Office
India Office